These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20595450)

  • 21. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
    Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
    Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).
    Lee J; Cho SG; Chung SM; Ryu MR; Kim SH; Jang HS; Choi BO
    Ann Hematol; 2013 Mar; 92(3):333-43. PubMed ID: 23180438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and prognostic model for extranasal NK/T-cell lymphoma.
    Jo JC; Yoon DH; Kim S; Lee BJ; Jang YJ; Park CS; Huh J; Lee SW; Ryu JS; Suh C
    Eur J Haematol; 2012 Aug; 89(2):103-10. PubMed ID: 22553935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma.
    Li ZM; Zhu YJ; Sun J; Xia Y; Huang JJ; Zou BY; Lin TY; Huang HQ; Jiang WQ
    Ann Hematol; 2012 Aug; 91(8):1265-70. PubMed ID: 22373550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
    Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
    Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type.
    Jiang L; Li P; Wang H; Liu J; Zhang X; Qiu H; Zhang B
    Med Oncol; 2014 Oct; 31(10):218. PubMed ID: 25204411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma.
    Li N; Jiang M; Wu WC; Zou LQ
    Ann Hematol; 2022 Jul; 101(7):1545-1556. PubMed ID: 35635579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.
    Oki Y; Yamamoto K; Kato H; Kuwatsuka Y; Taji H; Kagami Y; Morishima Y
    Eur J Haematol; 2008 Dec; 81(6):448-53. PubMed ID: 18691256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal pretreatment coagulation factor levels correlate with poor prognosis in patients with early-stage extranodal nasal-type natural/killer T cell lymphoma.
    Chai Y; Qi F; Chen B; Gui L; Yang J; Qi S; Song Y; Li Y; Wei Y; Dong M
    Ann Hematol; 2020 Jun; 99(6):1303-1309. PubMed ID: 32333152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma.
    Cox MC; Nofroni I; Ruco L; Amodeo R; Ferrari A; La Verde G; Cardelli P; Montefusco E; Conte E; Monarca B; Aloe-Spiriti MA
    Leuk Lymphoma; 2008 Sep; 49(9):1745-51. PubMed ID: 18798109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD30-positive cutaneous extranodal natural killer/T-cell lymphoma: clinicopathological features and survival outcomes.
    Lee WJ; Moon IJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
    Int J Dermatol; 2019 Jun; 58(6):688-696. PubMed ID: 30597548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemoglobin level, a prognostic factor for nasal extranodal natural killer/T-cell lymphoma patients from stage I to IV: A validated prognostic nomogram.
    Cao J; Lan S; Shen L; Si H; Xiao H; Yuan Q; Li X; Li H; Guo R
    Sci Rep; 2017 Sep; 7(1):10982. PubMed ID: 28887511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.
    Wang L; Xia ZJ; Lu Y; Wang QX; Niu SQ; Huang HQ; Zhang YJ
    Leuk Lymphoma; 2015; 56(11):3038-44. PubMed ID: 25747971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.
    Zhang H; Li ZL; Ye SB; Ouyang LY; Chen YS; He J; Huang HQ; Zeng YX; Zhang XS; Li J
    Cancer Immunol Immunother; 2015 Dec; 64(12):1587-99. PubMed ID: 26497849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trial of LVDP regimen (L-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphoma.
    Wang YQ; Yang Y; Zhuo HY; Zou LQ; Jiang Y; Jiang M
    Med Oncol; 2015 Feb; 32(2):435. PubMed ID: 25572807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beclin 1 expression: a predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type.
    Huang JJ; Li HR; Huang Y; Jiang WQ; Xu RH; Huang HQ; Lv Y; Xia ZJ; Zhu XF; Lin TY; Li ZM
    Autophagy; 2010 Aug; 6(6):777-83. PubMed ID: 20639699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New prognostic model for extranodal natural killer/T cell lymphoma, nasal type.
    Cai Q; Luo X; Zhang G; Huang H; Huang H; Lin T; Jiang W; Xia Z; Young KH
    Ann Hematol; 2014 Sep; 93(9):1541-9. PubMed ID: 24782120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical Characteristics and Prognostic Analysis of Extranodal NK/T-Cell Lymphoma Patients Treated with Pegaspargase Based Chemotherapy].
    Wei C; Zhang Y; Wang W; Zhang L; Zhang W; Zhou DB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):735-740. PubMed ID: 34105466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel and simple prognostic index for nasal natural killer/T-cell lymphoma.
    Hanakawa H; Orita Y; Sato Y; Takao S; Marunaka H; Morishita T; Yamashita Y; Hori Y; Domae S; Inokuchi I; Akagi S; Kondo E; Iwaki N; Motomiya K; Okumura H; Yoshino T; Nishizaki K
    Head Neck; 2014 Apr; 36(4):551-6. PubMed ID: 23780926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infused Autograft Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched Case-Control Study.
    Porrata LF; Burgstaler EA; Winters JL; Jacob E; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Villasboas J; Paludo J; Markovic SN
    Transplant Cell Ther; 2021 Sep; 27(9):769.e1-769.e8. PubMed ID: 34091071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.